LT3237432T - Baltymo gamyba - Google Patents

Baltymo gamyba

Info

Publication number
LT3237432T
LT3237432T LTEPPCT/EP2015/080561T LTEP2015080561T LT3237432T LT 3237432 T LT3237432 T LT 3237432T LT EP2015080561 T LTEP2015080561 T LT EP2015080561T LT 3237432 T LT3237432 T LT 3237432T
Authority
LT
Lithuania
Prior art keywords
protein
production
Prior art date
Application number
LTEPPCT/EP2015/080561T
Other languages
English (en)
Inventor
Philip Bassett
Richard Davies
Elena Gonzalez
Mark PEARCE-HIGGINS
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52292664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3237432(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of LT3237432T publication Critical patent/LT3237432T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/145Extraction; Separation; Purification by extraction or solubilisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241Tumor Necrosis Factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
LTEPPCT/EP2015/080561T 2014-12-22 2015-12-18 Baltymo gamyba LT3237432T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14199717 2014-12-22
PCT/EP2015/080561 WO2016102383A1 (en) 2014-12-22 2015-12-18 Protein manufacture

Publications (1)

Publication Number Publication Date
LT3237432T true LT3237432T (lt) 2023-12-11

Family

ID=52292664

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2015/080561T LT3237432T (lt) 2014-12-22 2015-12-18 Baltymo gamyba

Country Status (24)

Country Link
US (1) US10358460B2 (lt)
EP (2) EP4253548A3 (lt)
JP (1) JP6807327B2 (lt)
KR (1) KR102533455B1 (lt)
CN (1) CN107108692B (lt)
AU (1) AU2015371346B2 (lt)
BR (1) BR112017013394B1 (lt)
CA (1) CA2969889A1 (lt)
CL (1) CL2017001632A1 (lt)
CO (1) CO2017006156A2 (lt)
DK (1) DK3237432T3 (lt)
EA (1) EA201791424A1 (lt)
ES (1) ES2965032T3 (lt)
FI (1) FI3237432T3 (lt)
HR (1) HRP20231408T1 (lt)
IL (1) IL252696B (lt)
LT (1) LT3237432T (lt)
MX (1) MX390701B (lt)
MY (1) MY180732A (lt)
PL (1) PL3237432T3 (lt)
PT (1) PT3237432T (lt)
SG (1) SG11201704836XA (lt)
SI (1) SI3237432T1 (lt)
WO (1) WO2016102383A1 (lt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
IL252712B2 (en) 2014-12-22 2024-04-01 UCB Biopharma SRL Method of protein manufacture
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720833D0 (en) 1987-09-04 1987-10-14 Celltech Ltd Recombinant dna product
GB9215540D0 (en) * 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
FR2716640B1 (fr) 1994-02-28 1996-05-03 Procedes Machines Speciales Dispositif de centrage et de blocage d'une pièce en vue de son rodage à l'aide d'un rodoir à expansion.
US5655866A (en) 1995-03-20 1997-08-12 Bellanca; Joseph V. Method of folding a signature for use in bookbinding
GB9625640D0 (en) 1996-12-10 1997-01-29 Celltech Therapeutics Ltd Biological products
TWI334439B (en) 2001-08-01 2010-12-11 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
US7052916B2 (en) 2002-05-24 2006-05-30 Immunex Corporation Polypeptide analyses using stable isotope labeling
GB0319601D0 (en) 2003-08-20 2003-09-24 Sandoz Ag Production process
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201001791D0 (en) * 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
PL2731973T3 (pl) 2011-07-13 2018-04-30 Ucb Biopharma Sprl Bakteryjny szczep gospodarz wykazujący ekspresję dsbc
IL252712B2 (en) 2014-12-22 2024-04-01 UCB Biopharma SRL Method of protein manufacture

Also Published As

Publication number Publication date
PL3237432T3 (pl) 2024-03-04
US20170362272A1 (en) 2017-12-21
IL252696B (en) 2021-04-29
PT3237432T (pt) 2023-11-28
SI3237432T1 (sl) 2023-12-29
MX2017007684A (es) 2017-10-27
SG11201704836XA (en) 2017-07-28
BR112017013394A2 (pt) 2018-03-06
CN107108692B (zh) 2021-01-29
CA2969889A1 (en) 2016-06-30
KR102533455B1 (ko) 2023-05-16
EP4253548A2 (en) 2023-10-04
EA201791424A1 (ru) 2017-10-31
ES2965032T3 (es) 2024-04-10
JP6807327B2 (ja) 2021-01-06
HRP20231408T1 (hr) 2024-02-16
AU2015371346A1 (en) 2017-06-29
IL252696A0 (en) 2017-08-31
EP3237432A1 (en) 2017-11-01
WO2016102383A1 (en) 2016-06-30
JP2018505693A (ja) 2018-03-01
BR112017013394B1 (pt) 2024-02-06
AU2015371346B2 (en) 2021-05-13
CN107108692A (zh) 2017-08-29
DK3237432T3 (da) 2023-11-20
MX390701B (es) 2025-03-21
EP3237432B1 (en) 2023-09-06
EP4253548A3 (en) 2024-01-03
US10358460B2 (en) 2019-07-23
FI3237432T3 (fi) 2023-11-03
CO2017006156A2 (es) 2017-09-11
KR20170093984A (ko) 2017-08-16
CL2017001632A1 (es) 2017-11-24
MY180732A (en) 2020-12-08

Similar Documents

Publication Publication Date Title
PL3167096T3 (pl) Dwuetapowy sposób nanoszenia
EP3161143C0 (en) PRODUCTION OF OLIGOSACCHARIDES
EP3461890C0 (en) TOTAL FERMENTATION OF OLIGOSACCHARIDES
LT3237432T (lt) Baltymo gamyba
DK3453721T3 (da) Process of manufacture of annexin v
GB201518792D0 (en) Production of proteins
DK3132009T3 (da) Fremgangsmåde
DK3283210T3 (da) Fremgangsmåde
DK3099791T3 (da) Protein
LT3212237T (lt) Metotreksato vaistinė forma
HUE049170T2 (hu) Eljárás szubsztituált cikloszerinek elõállítására
EP3323166A4 (en) AUTOMATED MANUFACTURE OF A BIONANO CATALYST
BR112017009040A2 (pt) produção de um material de espinélio
IL254502A0 (en) Solid forms of menaquinols
HRP20182029T1 (hr) Uti-fuzijski proteini
HRP20181805T1 (hr) Postupak za proizvodnju poligvanidina
DK3099793T3 (da) Protein
EP3526234A4 (en) PRODUCTION OF RECOMBINANT MICROCYSTINE
IL252712A0 (en) Method for protein production
FI20155387A7 (fi) Sterolien tuottaminen
FR3024647B1 (fr) Transat de puericulture
DK3285588T3 (da) Fremgangsmåde
DK3206821T3 (da) Hulfrembringelsessystem
ES1101930Y (es) Pulsera portagomas
PL3350308T3 (pl) Zastosowanie włókna liocelowego